To evaluate the role of TMPRSS2 expression in lung cancer progression in vivo, we examined the expression levels of TMPRSS2, IL18, and nuclear AhR by IHC in tumor specimens from 25 lung cancer patients. This evidence concerns the gene AHR and neoplasm.